Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Chloride, Morphine
2. Contin, Ms
3. Duramorph
4. Morphia
5. Morphine
6. Morphine Chloride
7. Morphine Sulfate
8. Morphine Sulfate (2:1), Anhydrous
9. Morphine Sulfate (2:1), Pentahydrate
10. Ms Contin
11. Oramorph Sr
12. Sdz 202 250
13. Sdz 202-250
14. Sdz 202250
15. Sdz202 250
16. Sdz202-250
17. Sdz202250
18. Sulfate, Morphine
1. Morphine Sulfate
2. Schembl29317
3. Morphinesulfatenarcoticanalgesic
Molecular Weight | 383.4 g/mol |
---|---|
Molecular Formula | C17H21NO7S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 0 |
Exact Mass | 383.10387318 g/mol |
Monoisotopic Mass | 383.10387318 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 576 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Astramorph pf |
PubMed Health | Morphine (Injection) |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
2 of 6 | |
---|---|
Drug Name | Duramorph pf |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Hikma Maple |
3 of 6 | |
---|---|
Drug Name | Morphine sulfate |
PubMed Health | Morphine Sulfate Liposome (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | DESCRIPTIONChemically, morphine sulfate is 7, 8-didehydro-4, 5-epoxy-17-methylmorphinan-3, 6-diol sulfate (2:1) (salt) pentahydrate... |
Active Ingredient | Morphine sulfate |
Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release; Solution |
Route | Intramuscular, intravenous; oral; Injection; Oral |
Strength | 2mg/ml; 200mg; 10mg/5ml; 1mg/ml; 8mg/ml (8mg/ml); 30mg; 10mg/ml (10mg/ml); 100mg/5ml; 90mg; 15mg; 120mg; 4mg/ml (4mg/ml); 10mg/ml; 0.5mg/ml; 2mg/ml (2mg/ml); 75mg; 4mg/ml; 5mg/ml; 100mg; 5mg/ml (5mg/ml); 8mg/ml; 50mg; 60mg; 10mg; 15mg/ml; 20mg/5ml; 80mg; |
Market Status | Prescription |
Company | Clonmel Hlthcare; Vintage Pharms; Mylan Pharms; Upsher Smith; Hospira; Mallinckrodt; Rhodes Pharms; Meridian Medcl; Par Pharm; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Paddock; Caraco; Ranbaxy Labs; Bd Rx |
4 of 6 | |
---|---|
Drug Name | Astramorph pf |
PubMed Health | Morphine (Injection) |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
5 of 6 | |
---|---|
Drug Name | Duramorph pf |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Hikma Maple |
6 of 6 | |
---|---|
Drug Name | Morphine sulfate |
PubMed Health | Morphine Sulfate Liposome (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | DESCRIPTIONChemically, morphine sulfate is 7, 8-didehydro-4, 5-epoxy-17-methylmorphinan-3, 6-diol sulfate (2:1) (salt) pentahydrate... |
Active Ingredient | Morphine sulfate |
Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release; Solution |
Route | Intramuscular, intravenous; oral; Injection; Oral |
Strength | 2mg/ml; 200mg; 10mg/5ml; 1mg/ml; 8mg/ml (8mg/ml); 30mg; 10mg/ml (10mg/ml); 100mg/5ml; 90mg; 15mg; 120mg; 4mg/ml (4mg/ml); 10mg/ml; 0.5mg/ml; 2mg/ml (2mg/ml); 75mg; 4mg/ml; 5mg/ml; 100mg; 5mg/ml (5mg/ml); 8mg/ml; 50mg; 60mg; 10mg; 15mg/ml; 20mg/5ml; 80mg; |
Market Status | Prescription |
Company | Clonmel Hlthcare; Vintage Pharms; Mylan Pharms; Upsher Smith; Hospira; Mallinckrodt; Rhodes Pharms; Meridian Medcl; Par Pharm; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Paddock; Caraco; Ranbaxy Labs; Bd Rx |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-08-29
Pay. Date : 2014-08-18
DMF Number : 21588
Submission : 2008-04-30
Status : Active
Type : II
Certificate Number : CEP 2001-239 - Rev 07
Issue Date : 2024-06-20
Type : Chemical
Substance Number : 1244
Status : Valid
NDC Package Code : 49812-0149
Start Marketing Date : 2005-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Baeksu Pharmaceutical Co., Ltd.
Registration Date : 2021-07-13
Registration Number : 20190812-209-J-406(2)
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom
Available Reg Filing : ROW |
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Certificate Number : CEP 2000-126 - Rev 07
Issue Date : 2024-04-26
Type : Chemical
Substance Number : 1244
Status : Valid
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-05
Pay. Date : 2012-11-23
DMF Number : 6967
Submission : 1987-05-08
Status : Active
Type : II
NDC Package Code : 51634-0969
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-19
Pay. Date : 2015-12-10
DMF Number : 29317
Submission : 2015-11-25
Status : Active
Type : II
NDC Package Code : 51634-0969
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20264
Submission : 2007-02-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6680
Submission : 1986-11-20
Status : Inactive
Type : II
Certificate Number : CEP 2005-211 - Rev 02
Issue Date : 2024-05-13
Type : Chemical
Substance Number : 1244
Status : Valid
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Morphine Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Morphine Sulfate, including repackagers and relabelers. The FDA regulates Morphine Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Morphine Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Morphine Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Morphine Sulfate supplier is an individual or a company that provides Morphine Sulfate active pharmaceutical ingredient (API) or Morphine Sulfate finished formulations upon request. The Morphine Sulfate suppliers may include Morphine Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Morphine Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Morphine Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Morphine Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Morphine Sulfate DMFs exist exist since differing nations have different regulations, such as Morphine Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Morphine Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Morphine Sulfate USDMF includes data on Morphine Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Morphine Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Morphine Sulfate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Morphine Sulfate Drug Master File in Korea (Morphine Sulfate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Morphine Sulfate. The MFDS reviews the Morphine Sulfate KDMF as part of the drug registration process and uses the information provided in the Morphine Sulfate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Morphine Sulfate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Morphine Sulfate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Morphine Sulfate suppliers with KDMF on PharmaCompass.
A Morphine Sulfate CEP of the European Pharmacopoeia monograph is often referred to as a Morphine Sulfate Certificate of Suitability (COS). The purpose of a Morphine Sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Morphine Sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Morphine Sulfate to their clients by showing that a Morphine Sulfate CEP has been issued for it. The manufacturer submits a Morphine Sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Morphine Sulfate CEP holder for the record. Additionally, the data presented in the Morphine Sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Morphine Sulfate DMF.
A Morphine Sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Morphine Sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Morphine Sulfate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Morphine Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Morphine Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Morphine Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Morphine Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Morphine Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Morphine Sulfate suppliers with NDC on PharmaCompass.
Morphine Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Morphine Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Morphine Sulfate GMP manufacturer or Morphine Sulfate GMP API supplier for your needs.
A Morphine Sulfate CoA (Certificate of Analysis) is a formal document that attests to Morphine Sulfate's compliance with Morphine Sulfate specifications and serves as a tool for batch-level quality control.
Morphine Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Morphine Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Morphine Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Morphine Sulfate EP), Morphine Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Morphine Sulfate USP).
LOOKING FOR A SUPPLIER?